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Purpose: We can treat symptoms of GERD effectively by
traditional medicine. And empirically we know there are
many “heat syndrome” patients in GERD. But we don’t have
standard syndrome differentiation questionnaire and don’t
know prevalence of each syndrome.
Methods: We searched ‘GERD’ and ‘syndrome differenti-
ation’ in CNKI and PubMed for last 10 years article. Then,
we selected only clinical trials that categorized patients by
‘syndrome differentiation’ and reported the number of the
patients according to each syndrome. Next, we classiﬁed
them by syndrome differentiation and counted the number
of patients according to each syndrome. Next, to survey cause
of the disease, we re-classiﬁed them by cause of the disease.
For instance, if there were letter ‘heat’ or ‘ﬁre’ in the name
of each syndrome differentiation, we classiﬁed the syndrome
into “heat syndrome”. Finally we counted the total number of
the “‘heat syndrome” patients.
Results: We could extract data of 1157 patients from 10
years clinical trial that had classiﬁed the patients according to
syndromedifferentiation. Therewere 22 syndromepatterns in
GERD patients. The syndrome appeared most was ‘liver and
stomach heat stagnation’ (398pts). And the total percentage
of the patients who were classiﬁed into heat syndrome was
51.17%.
Conclusion: We found that more than half of the
GERD patients classiﬁed into “heat syndrome” by traditional
medicine. Now we are trying to make standard question-
naire of GERD. We could get cut-off score of “heat syndrome”
through the work. The prevalence data of “heat syndrome”
will be very helpful because we can predict post-test proba-
bility with prevalence and cut-off score of “heat syndrome”.
Final goal of our research team is conducting a clinical trial to
treat GERD by traditional medicine. This study was supported
by the Traditional Korean Medicine R&D program funded by
the Ministry of Health and Welfare through the Korean Health
Industry Development Institute (KHIDI) (No. HI13C0700)
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Purpose: The purpose of this study is to report a case series
of two patients with chemotherapy induced neutropenia who
prescribed herbal medicine during their period of hospitaliza-
tion.
Methods: Samultanggagambang was prescribed three
times a day to two patients with chemotherapy induced neu-
tropenia. Complete blood cell count is measured before and
after administration of samultanggagambang.
Results: ANC (Absolute Neutrophil Count) was gradually
increased during the administration of samultanggagambang.
Case 1 was a 51-year-old female patient. The initial diagnosis
was made in December, 2013 with right breast cancer, IIB
(pT 2N1M0). Neoadjuvant chemotherapy was administered
from December, 2013 to February, 2014. Partial mastectomy
was performed on March, 2014. Adjuvant chemotherapy was
administered from April, 2014 every three weeks with Doc-
etaxel. The patient was hospitalized on 19, May after second
chemotherapy on 12, May. The patient was isolated in single
room on 20, May with ANC 340. Filgrastim was administered
once and Samultanggagambang was prescribed three times
a day. ANC was recovered as 2083 on 26, May. Case 2 was a
46-year-old female patient. The initial diagnosis was made in
April, 2014 with advanced gastric cancer, IIIB (pT3N2M0). A
total gastrectomy was performed on two weeks later. Adju-
vant chemotherapy was administered from May, 2014 every
three weeks with Xeloda and Oxaliplatin. The patient was
hospitalized on 19, May after ﬁrst chemotherapy on 15, May.
The patient was isolated in multi-bed room on 20, May with
ANC 974. Samultanggagambang was prescribed three times
a day. Even though, Capecitabine 2,300mg was administered
until 28, May ANC was recovered as 3,419 on 2, June.
Conclusion: Samultanggagambang has shown beneﬁt in
improving chemotherapy induced neutropenia. It is expected
to be a promising treatment for improving chemotherapy
induced neutropenia and more clinical research will be
required for evidence based medicine.
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